A real-world, observational retrospective study of leuprolide and relugolix in combination with other prostate cancer (PC) medications in patients for androgen deprivation therapy
Latest Information Update: 31 Mar 2023
At a glance
- Drugs Leuprorelin (Primary) ; Relugolix (Primary) ; Abiraterone; Apalutamide; Darolutamide; Enzalutamide
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms REAL-ADT COMBO Study
Most Recent Events
- 31 Mar 2023 New trial record
- 18 Feb 2023 Results presented at the 2023 Genitourinary Cancers Symposium